Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses SOLV in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named SOLV in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Bryan Hanson | $1,350,000 | $0 | $15,209,022 | $0 | $2,988,900 | $0 | $592,058 | $20,139,981 |
| Chief Executive Officer | ||||||||
| Heather Knight | 112,821 | 2,000,000 | 5,653,534 | 0 | 140,186 | 0 | 11,365 | 7,917,906 |
| Chief Commercial Officer | ||||||||
| Wayde McMillan | 773,229 | 0 | 4,195,688 | 0 | 1,118,221 | 0 | 78,445 | 6,165,583 |
| Chief Financial Officer | ||||||||
| Christopher Barry | 996,750 | 0 | 3,146,700 | 0 | 0 | 0 | 88,553 | 4,232,003 |
| Former EVP and Group President, Medical Surgical | ||||||||
| Marcela Kirberger | 728,651 | 0 | 1,992,885 | 0 | 773,085 | 0 | 99,396 | 3,594,017 |
| Chief Corporate & Legal Officer | ||||||||
| Amy Landucci | 684,875 | 0 | 1,809,409 | 0 | 871,969 | 0 | 98,723 | 3,464,975 |
| Chief Information & Digital Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Bryan Hanson | $20,139,981 | — | — | — |
| Heather Knight | 7,917,906 | — | — | — |
| Wayde McMillan | 6,165,583 | — | — | — |
| Christopher Barry | 4,232,003 | — | — | — |
| Marcela Kirberger | 3,594,017 | — | — | — |
| Amy Landucci | 3,464,975 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Dividend-equivalent accruals | 2026-03-27 | — | 19,800 | — | — | 10 insiders, 10 accrual rows | ||
| Mary T. Wilcox | Chief Accounting Officer | 2026-03-27 | A | 5,199 | 0 | 0 | Common | Form 4 ↗ |
| Mary T. Wilcox | Chief Accounting Officer | 2026-03-27 | D | 1,591 | 63 | 99,851 | Common | Form 4 ↗ |
| Carrie S. Cox | Director | 2026-03-27 | A | 6,336 | 0 | 0 | Common | Form 4 ↗ |
| Carrie S. Cox | Director | 2026-03-27 | D | 6,336 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Susan D. DeVore | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Glenn A. Eisenberg | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Elizabeth A. Mily | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Darryl L. Wilson | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Carlos Alban | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Amy A. Wendell | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Karen J. May | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Dr. Bernard A. Harris, Jr | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Mary T. Wilcox | Chief Accounting Officer | 2026-03-27 | D | 5,199 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John H. Weiland | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Shirley A. Edwards | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Carlos Alban | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| John H. Weiland | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Amy A. Wendell | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John H. Weiland | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Elizabeth A. Mily | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Darryl L. Wilson | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Darryl L. Wilson | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Karen J. May | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dr. Bernard A. Harris, Jr | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Glenn A. Eisenberg | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shirley A. Edwards | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Susan D. DeVore | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Susan D. DeVore | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carrie S. Cox | Director | 2026-04-30 | D | 4,916 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shirley A. Edwards | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carrie S. Cox | Director | 2026-04-30 | A | 4,916 | 0 | 0 | Common | Form 4 ↗ |
| Carlos Alban | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Elizabeth A. Mily | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Glenn A. Eisenberg | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Amy A. Wendell | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Dr. Bernard A. Harris, Jr | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Karen J. May | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Marcela Kirberger | Chief Legal Affairs Officer | 2026-05-13 | D | 1,952 | 74 | 145,248 | Common | Form 4 ↗ |
| Mary T. Wilcox | Chief Accounting Officer | 2026-05-13 | D | 728 | 74 | 54,170 | Common | Form 4 ↗ |
| Tammy L. Gomez | Chief Human Resources Officer | 2026-05-13 | A | 3,960 | 0 | 0 | Common | Form 4 ↗ |
| Tammy L. Gomez | Chief Human Resources Officer | 2026-05-13 | D | 1,668 | 74 | 124,116 | Common | Form 4 ↗ |
| Marcela Kirberger | Chief Legal Affairs Officer | 2026-05-13 | D | 4,488 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mary T. Wilcox | Chief Accounting Officer | 2026-05-13 | D | 2,376 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mary T. Wilcox | Chief Accounting Officer | 2026-05-13 | A | 2,376 | 0 | 0 | Common | Form 4 ↗ |
| Marcela Kirberger | Chief Legal Affairs Officer | 2026-05-13 | A | 4,488 | 0 | 0 | Common | Form 4 ↗ |
| Amy Landucci | Chief Information Officer | 2026-05-13 | D | 2,017 | 74 | 150,085 | Common | Form 4 ↗ |
| Bryan C. Hanson | Director | 2026-05-13 | D | 34,315 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Paul S. Harrington | Chief Supply Chain Officer | 2026-05-13 | D | 3,960 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Bryan C. Hanson | Director | 2026-05-13 | A | 34,315 | 0 | 0 | Common | Form 4 ↗ |
| Wayde McMillan | Chief Financial Officer | 2026-05-13 | D | 9,503 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Amy Landucci | Chief Information Officer | 2026-05-13 | A | 4,422 | 0 | 0 | Common | Form 4 ↗ |
| Wayde McMillan | Chief Financial Officer | 2026-05-13 | D | 4,404 | 74 | 327,702 | Common | Form 4 ↗ |
| Wayde McMillan | Chief Financial Officer | 2026-05-13 | A | 9,503 | 0 | 0 | Common | Form 4 ↗ |
| Paul S. Harrington | Chief Supply Chain Officer | 2026-05-13 | A | 3,960 | 0 | 0 | Common | Form 4 ↗ |
| Paul S. Harrington | Chief Supply Chain Officer | 2026-05-13 | D | 1,678 | 74 | 124,860 | Common | Form 4 ↗ |
| Tammy L. Gomez | Chief Human Resources Officer | 2026-05-13 | D | 3,960 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Amy Landucci | Chief Information Officer | 2026-05-13 | D | 4,422 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Bryan C. Hanson | Director | 2026-05-13 | D | 13,503 | 74 | 1,004,758 | Common | Form 4 ↗ |
| Glenn A. Eisenberg | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Darryl L. Wilson | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carrie S. Cox | Director | 2026-05-15 | A | 4,848 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Karen J. May | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Elizabeth A. Mily | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Susan D. DeVore | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shirley A. Edwards | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dr. Bernard A. Harris, Jr | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Amy A. Wendell | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John H. Weiland | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carlos Alban | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| John H. Weiland | Director | 2026-03-27 | D | 1,980 | $0 | $0 | Derivative, Class A Common | Form 4 ↗ |
| Carlos Alban | Director | 2026-03-27 | D | 1,980 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Amy A. Wendell | Director | 2026-03-27 | D | 1,980 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Darryl L. Wilson | Director | 2026-03-27 | D | 1,980 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mary T. Wilcox | Chief Accounting Officer | 2026-03-27 | A | 5,199 | 0 | 0 | Common | Form 4 ↗ |
| Mary T. Wilcox | Chief Accounting Officer | 2026-03-27 | D | 1,591 | 63 | 99,851 | Common | Form 4 ↗ |
| Carrie S. Cox | Director | 2026-03-27 | A | 6,336 | 0 | 0 | Common | Form 4 ↗ |
| Carrie S. Cox | Director | 2026-03-27 | D | 6,336 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Susan D. DeVore | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Shirley A. Edwards | Director | 2026-03-27 | D | 1,980 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Glenn A. Eisenberg | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Glenn A. Eisenberg | Director | 2026-03-27 | D | 1,980 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dr. Bernard A. Harris, Jr | Director | 2026-03-27 | D | 1,980 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Elizabeth A. Mily | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Darryl L. Wilson | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Carlos Alban | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Elizabeth A. Mily | Director | 2026-03-27 | D | 1,980 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Karen J. May | Director | 2026-03-27 | D | 1,980 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Amy A. Wendell | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Susan D. DeVore | Director | 2026-03-27 | D | 1,980 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Karen J. May | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Dr. Bernard A. Harris, Jr | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Mary T. Wilcox | Chief Accounting Officer | 2026-03-27 | D | 5,199 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John H. Weiland | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Shirley A. Edwards | Director | 2026-03-27 | A | 1,980 | 0 | 0 | Common | Form 4 ↗ |
| Carlos Alban | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| John H. Weiland | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Amy A. Wendell | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John H. Weiland | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Elizabeth A. Mily | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Darryl L. Wilson | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Darryl L. Wilson | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Karen J. May | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dr. Bernard A. Harris, Jr | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Glenn A. Eisenberg | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shirley A. Edwards | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Susan D. DeVore | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Susan D. DeVore | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carrie S. Cox | Director | 2026-04-30 | D | 4,916 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shirley A. Edwards | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carrie S. Cox | Director | 2026-04-30 | A | 4,916 | 0 | 0 | Common | Form 4 ↗ |
| Carlos Alban | Director | 2026-04-30 | D | 3,403 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Elizabeth A. Mily | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Glenn A. Eisenberg | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Amy A. Wendell | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Dr. Bernard A. Harris, Jr | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Karen J. May | Director | 2026-04-30 | A | 3,403 | 0 | 0 | Common | Form 4 ↗ |
| Marcela Kirberger | Chief Legal Affairs Officer | 2026-05-13 | D | 1,952 | 74 | 145,248 | Common | Form 4 ↗ |
| Mary T. Wilcox | Chief Accounting Officer | 2026-05-13 | D | 728 | 74 | 54,170 | Common | Form 4 ↗ |
| Tammy L. Gomez | Chief Human Resources Officer | 2026-05-13 | A | 3,960 | 0 | 0 | Common | Form 4 ↗ |
| Tammy L. Gomez | Chief Human Resources Officer | 2026-05-13 | D | 1,668 | 74 | 124,116 | Common | Form 4 ↗ |
| Marcela Kirberger | Chief Legal Affairs Officer | 2026-05-13 | D | 4,488 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mary T. Wilcox | Chief Accounting Officer | 2026-05-13 | D | 2,376 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mary T. Wilcox | Chief Accounting Officer | 2026-05-13 | A | 2,376 | 0 | 0 | Common | Form 4 ↗ |
| Marcela Kirberger | Chief Legal Affairs Officer | 2026-05-13 | A | 4,488 | 0 | 0 | Common | Form 4 ↗ |
| Amy Landucci | Chief Information Officer | 2026-05-13 | D | 2,017 | 74 | 150,085 | Common | Form 4 ↗ |
| Bryan C. Hanson | Director | 2026-05-13 | D | 34,315 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Paul S. Harrington | Chief Supply Chain Officer | 2026-05-13 | D | 3,960 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Bryan C. Hanson | Director | 2026-05-13 | A | 34,315 | 0 | 0 | Common | Form 4 ↗ |
| Wayde McMillan | Chief Financial Officer | 2026-05-13 | D | 9,503 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Amy Landucci | Chief Information Officer | 2026-05-13 | A | 4,422 | 0 | 0 | Common | Form 4 ↗ |
| Wayde McMillan | Chief Financial Officer | 2026-05-13 | D | 4,404 | 74 | 327,702 | Common | Form 4 ↗ |
| Wayde McMillan | Chief Financial Officer | 2026-05-13 | A | 9,503 | 0 | 0 | Common | Form 4 ↗ |
| Paul S. Harrington | Chief Supply Chain Officer | 2026-05-13 | A | 3,960 | 0 | 0 | Common | Form 4 ↗ |
| Paul S. Harrington | Chief Supply Chain Officer | 2026-05-13 | D | 1,678 | 74 | 124,860 | Common | Form 4 ↗ |
| Tammy L. Gomez | Chief Human Resources Officer | 2026-05-13 | D | 3,960 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Amy Landucci | Chief Information Officer | 2026-05-13 | D | 4,422 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Bryan C. Hanson | Director | 2026-05-13 | D | 13,503 | 74 | 1,004,758 | Common | Form 4 ↗ |
| Glenn A. Eisenberg | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Darryl L. Wilson | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carrie S. Cox | Director | 2026-05-15 | A | 4,848 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Karen J. May | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Elizabeth A. Mily | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Susan D. DeVore | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shirley A. Edwards | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dr. Bernard A. Harris, Jr | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Amy A. Wendell | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John H. Weiland | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carlos Alban | Director | 2026-05-15 | A | 3,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Bryan Hanson | PSU | 2025-03-06 | 47,862 | 95,723 | — | 191,446 | $7,958,962 |
| Amy Landucci | RSU | 2025-03-06 | — | — | 11,388 | — | 862,527 |
| Wayde McMillan | RSU | 2025-03-06 | — | — | 26,407 | — | 2,000,066 |
| Marcela Kirberger | RSU | 2025-03-06 | — | — | 12,543 | — | 950,007 |
| Heather Knight | RSU | 2025-11-17 | — | — | 78,751 | — | 5,653,534 |
| Christopher Barry | RSU | 2025-03-06 | — | — | 19,805 | — | 1,500,031 |
| Bryan Hanson | RSU | 2025-03-06 | — | — | 95,723 | — | 7,250,060 |
| Amy Landucci | PSU | 2025-03-06 | 5,694 | 11,388 | — | 22,776 | 946,881 |
| Christopher Barry | PSU | 2025-03-06 | 9,903 | 19,805 | — | 39,610 | 1,646,670 |
| Wayde McMillan | PSU | 2025-03-06 | 13,204 | 26,407 | — | 52,814 | 2,195,622 |
| Marcela Kirberger | PSU | 2025-03-06 | 6,272 | 12,543 | — | 25,086 | 1,042,878 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Bryan Hanson | $7,250,060 | $7,958,962 | $0 | 52.3% |
| Amy Landucci | 862,527 | 946,881 | 0 | 52.3% |
| Wayde McMillan | 2,000,066 | 2,195,622 | 0 | 52.3% |
| Marcela Kirberger | 950,007 | 1,042,878 | 0 | 52.3% |
| Heather Knight | 5,653,534 | 0 | 0 | 0.0% |
| Christopher Barry | 1,500,031 | 1,646,670 | 0 | 52.3% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Christopher Barry | RSU | 118,786 | — | $9,412,603 |
| Wayde McMillan | RSU | 57,018 | — | 4,518,106 |
| Amy Landucci | RSU | 26,921 | — | 2,158,756 |
| Wayde McMillan | RSU | 26,407 | — | 2,092,491 |
| Amy Landucci | RSU | 22,776 | — | 1,804,770 |
| Bryan Hanson | RSU | 506,812 | — | 40,159,783 |
| Bryan Hanson | RSU | 205,892 | — | 16,314,882 |
| Bryan Hanson | RSU | 191,446 | — | 15,170,181 |
| Wayde McMillan | RSU | 158,380 | — | 12,550,031 |
| Bryan Hanson | RSU | 95,723 | — | 7,585,091 |
| Heather Knight | RSU | 78,751 | — | 6,240,229 |
| Christopher Barry | RSU | 29,036 | — | 2,300,813 |
| Marcela Kirberger | RSU | 12,543 | — | 993,907 |
| Amy Landucci | RSU | 8,844 | — | 700,799 |
| Bryan Hanson | RSU | 68,631 | — | 5,438,320 |
| Marcela Kirberger | RSU | 25,086 | — | 1,987,815 |
| Christopher Barry | RSU | 13,204 | — | 1,046,285 |
| Amy Landucci | RSU | 11,388 | — | 902,385 |
| Marcela Kirberger | RSU | 8,976 | — | 711,258 |
| Marcela Kirberger | RSU | 53,850 | — | 4,267,074 |
| Bryan Hanson | RSU | 67,261 | — | 5,456,941 |
| Amy Landucci | RSU | 53,058 | — | 4,204,316 |
| Amy Landucci | RSU | 26,530 | — | 2,102,237 |
| Wayde McMillan | RSU | 52,814 | — | 4,184,981 |
| Marcela Kirberger | RSU | 26,926 | — | 2,133,616 |
| Wayde McMillan | RSU | 19,007 | — | 1,506,115 |
The Solventum Talent Committee designed the executive compensation program to incentivize and reward executives for actions that create sustainable shareholder value. The four key tenets of our compensation philosophy are: Pay For Performance: A majority of total direct compensation should be at risk and subject to preset goals that support our strategy, performance, and long-term shareholder value. Align Interests: Pay outcomes should be linked to the creation of shareholder value, aligning the interests of executives with shareholders. Retain Talent: The program should attract and retain industry-leading executives who lead the efforts to generate durable shareholder value. Reward Competitively: The program should be designed so that it is appropriately benchmarked and rewards strong performance.
| CEO STI target (% of salary) | 150% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Korn Ferry |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-15 | 105,240,522 | 36,603,358 | 564,163 | 74.19% | Passed |
| 2025 | 2025-04-30 | 117,421,361 | 19,247,470 | 866,600 | 85.92% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-05-15 | 74.19%a |
| 2025 | 2025-04-30 | 85.92%b |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 245 : 1 |
|---|---|
| CEO total compensation | $20,139,981 |
| Median employee compensation | $82,152 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Carrie S. CoxIndependent · Board Chair · Talent | $170,000 | $325,046 | $0 | $0 | $0 | $495,046 |
| Glenn A. EisenbergIndependent · Audit (Chair) | 145,000 | 225,006 | 0 | 0 | 0 | 370,006 |
| Karen J. MayIndependent · Talent (Chair) | 140,000 | 225,006 | 0 | 0 | 0 | 365,006 |
| Susan D. DeVoreIndependent · Governance (Chair) | 135,000 | 225,006 | 0 | 0 | 0 | 360,006 |
| John H. WeilandIndependent · Science, Technology and Quality (Chair) | 135,000 | 225,006 | 0 | 0 | 0 | 360,006 |
| Dr. Bernard A. Harris, JrIndependent · Science, Technology and Quality | 120,000 | 225,006 | 0 | 0 | 0 | 345,006 |
| Elizabeth A. MilyIndependent · Audit | 120,000 | 225,006 | 0 | 0 | 0 | 345,006 |
| Shirley A. EdwardsIndependent · Talent | 120,000 | 225,006 | 0 | 0 | 0 | 345,006 |
| Darryl L. WilsonIndependent · Talent | 120,000 | 225,006 | 0 | 0 | 0 | 345,006 |
| Carlos AlbánIndependent · Talent | 120,000 | 225,006 | 0 | 0 | 0 | 345,006 |
| Amy A. WendellIndependent · Audit | 120,000 | 225,006 | 0 | 0 | 0 | 345,006 |
| Bryan C. HansonEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $120,000 |
|---|---|
| Annual equity retainer | $225,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 15,000 |
| Stock ownership guideline | 5x Annual Retainer |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,445,000 |
| Equity awards (grant-date value) | $2,575,106 |
| All other compensation | $0 |
| Total cost of the board | $4,020,106 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Solventum Corp names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Solventum Corp.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Baxter International Inc. | 2025 | Andrew Hider | $499,315 | $23,133,518 | $3,185,053 | $820,125 | $29,805,182 |
| 2 | IQVIA Holdings Inc. | 2025 | Ari Bousbib | 1,800,000 | 15,749,957 | 4,528,317 | 4,966,127 | 28,128,245 |
| 3 | Danaher Corporation | 2025 | Rainer Blair | 1,400,000 | 9,292,370 | 8,386,657 | 4,194,400 | 23,795,280 |
| 4 | Boston Scientific Corporation | 2025 | Michael Mahoney | 1,442,603 | 13,608,056 | 3,749,980 | 4,002,001 | 23,532,050 |
| 5 | Medtronic plc | 2026 | Geoffrey Martha | 1,399,039 | 13,672,200 | 5,175,559 | 2,307,200 | 22,940,252 |
| 6 | Stryker Corporation | 2025 | Kevin Lobo | 1,500,000 | 16,684,917 | 0 | 2,250,000 | 21,401,495 |
| 7 | Intuitive Surgical, Inc. | 2025 | David Rosa | 858,750 | 18,674,872 | 0 | 1,373,859 | 20,997,480 |
| 8 | Solventum Corp | 2025 | Bryan Hanson | 1,350,000 | 15,209,022 | 0 | 2,988,900 | 20,139,981 |
| 9 | Align Technology, Inc. | 2025 | Joseph Hogan | 1,400,000 | 16,556,872 | 0 | 1,220,100 | 19,193,988 |
| 10 | GE HealthCare Technologies Inc. | 2025 | Peter Arduini | 1,324,983 | 11,249,533 | 3,624,970 | 2,081,084 | 18,562,794 |
| 11 | Edwards Lifesciences Corporation | 2025 | Bernard Zovighian | 1,192,500 | 7,167,024 | 6,499,109 | 2,406,537 | 17,454,255 |
| 12 | Becton, Dickinson and Company | 2025 | Thomas Polen | 1,395,463 | 9,991,854 | 3,311,861 | 1,852,010 | 17,129,140 |
| 13 | Zimmer Biomet Holdings, Inc. | 2025 | Ivan Tornos | 1,281,846 | 12,000,101 | 0 | 2,420,767 | 16,106,550 |
| 14 | The Cooper Companies, Inc. | 2025 | Albert White III | 1,170,769 | 6,642,918 | 6,643,050 | 1,525,951 | 16,051,141 |
| 15 | Hologic, Inc. | 2024 | Stephen MacMillan | 1,212,628 | 9,141,468 | 2,937,477 | 1,990,413 | 15,819,261 |
| 16 | ResMed Inc. | 2025 | Michael Farrell | 1,214,150 | 8,775,059 | 2,925,007 | 1,646,743 | 14,674,543 |
| 17 | Fortive Corporation | 2025 | Olumide Soroye | 931,733 | 8,196,125 | 3,706,519 | 1,358,100 | 14,405,012 |
| 18 | Agilent Technologies, Inc. | 2025 | Padraig McDonnell | 1,141,345 | 8,169,850 | 2,017,759 | 1,436,809 | 12,827,236 |
| 19 | STERIS plc | 2026 | Daniel Carestio | 1,095,707 | 4,333,951 | 4,334,251 | 1,725,007 | 11,508,522 |
| 20 | DENTSPLY SIRONA Inc. | 2025 | Daniel Scavilla | 431,753 | 3,484,488 | 3,221,523 | 437,150 | 8,760,139 |
| 21 | Avantor, Inc. | 2025 | Emmanuel Ligner | 379,297 | 2,499,990 | 2,499,998 | 330,038 | 5,895,624 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Solventum Corp | 123% | PSU 50 · RSU 50 | Yes — 3-year rTSR | Korn Ferry |
| Agilent Technologies, Inc. | not disclosed | PSU 60 · Options 20 · RSU 20 | No | Semler Brossy |
| Align Technology, Inc. | 58.1% | MSU 70 · RSU 30 | Yes — Relative Total Stockholder Return (TSR) vs. Nasdaq Composite Index | Compensia, Inc. |
| Avantor, Inc. | 56.9% | PSU 50 · Options 25 · RSU 25 | Yes — TSR Relative to Comparator Group | FW Cook |
| Baxter International Inc. | not disclosed | PSU 50 · Stock Options 25 · RSU 25 | not disclosed | Aon |
| Becton, Dickinson and Company | 85% | PSU 50 · Options 25 · RSU 25 | No | Semler Brossy |
| Boston Scientific Corporation | 173% | PSU 50 · RSU 25 · Options 25 | No | Semler Brossy Consulting Group, LLC |
| Danaher Corporation | not disclosed | Options 50 · RSU 50 | not disclosed | FW Cook |
| DENTSPLY SIRONA Inc. | 66% | PSU 50 · Options 50 | No | Frederic W. Cook & Co., Inc. |
| Edwards Lifesciences Corporation | 127% | Options 50 · PSU 25 · RSU 25 | No | Semler Brossy Consulting Group |
| Fortive Corporation | not disclosed | PSU 50 · RSU 25 · Options 25 | Yes — Relative TSR vs. S&P 500 | Pearl Meyer |
| GE HealthCare Technologies Inc. | 101% | PSU 50 · Options 25 · RSU 25 | No | Semler Brossy |
| Hologic, Inc. | 109% | PSU 50 · RSU 25 · Options 25 | No | not disclosed |
| Intuitive Surgical, Inc. | 115.2% | RSU 50 · PSU 50 | No | Aon |
| IQVIA Holdings Inc. | not disclosed | PSU 75 · Options 25 | Yes | Meridian Compensation Partners, LLC |
| Medtronic plc | 103% | PSU 50 · Options 30 · RSU 20 | No | Semler Brossy |
| ResMed Inc. | 102% | PSU 50 · RSU 25 · Options 25 | Yes — Absolute TSR | FW Cook, Inc. |
| STERIS plc | 125.1% | RSU 50 · Options 50 | not disclosed | Frederic W. Cook & Co., Inc. |
| Stryker Corporation | 100% | PSU 48 · Options 34 | No | Semler Brossy |
| The Cooper Companies, Inc. | 100.9% | Options 50 · PSU 50 | No | Compensia |
| Zimmer Biomet Holdings, Inc. | 125.9% | RSU 50 · PSU 50 | Yes — Relative TSR | Semler Brossy |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Bryan Hanson | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Summary compensation table”. As printed: 20,139,981. Filing ↗machine: r4 · c30 · span 1137286–1137296 |
| 2 | Section 01, Heather Knight | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Summary compensation table”. As printed: 7,917,906. Filing ↗machine: r14 · c30 · span 1150766–1150775 |
| 3 | Section 01, Wayde McMillan | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Summary compensation table”. As printed: 6,165,583. Filing ↗machine: r9 · c30 · span 1143596–1143605 |
| 4 | Section 01, Christopher Barry | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Summary compensation table”. As printed: 4,232,003. Filing ↗machine: r25 · c30 · span 1166774–1166783 |
| 5 | Section 01, Marcela Kirberger | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Summary compensation table”. As printed: 3,594,017. Filing ↗machine: r17 · c30 · span 1154970–1154979 |
| 6 | Section 01, Amy Landucci | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Summary compensation table”. As printed: 3,464,975. Filing ↗machine: r20 · c30 · span 1159288–1159297 |
| 7 | Section 03, Bryan Hanson PSU | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Grants of plan-based awards” · grants of plan-based awards table. Filing ↗machine: t178 · r9 · c12 · span 1229847–1229853 |
| 8 | Section 03, Amy Landucci RSU | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Grants of plan-based awards” · grants of plan-based awards table. Filing ↗machine: t178 · r35 · c12 · span 1294824–1294830 |
| 9 | Section 03, Wayde McMillan RSU | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Grants of plan-based awards” · grants of plan-based awards table. Filing ↗machine: t178 · r16 · c12 · span 1247559–1247565 |
| 10 | Section 03, Marcela Kirberger RSU | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Grants of plan-based awards” · grants of plan-based awards table. Filing ↗machine: t178 · r28 · c11 · span 1277436–1277442 |
| 11 | Section 03, Heather Knight RSU | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Grants of plan-based awards” · grants of plan-based awards table. Filing ↗machine: t178 · r23 · c17 · span 1266001–1266007 |
| 12 | Section 03, Christopher Barry RSU | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Grants of plan-based awards” · grants of plan-based awards table. Filing ↗machine: t178 · r42 · c12 · span 1312530–1312536 |
| 13 | Section 03, Bryan Hanson RSU | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Grants of plan-based awards” · grants of plan-based awards table. Filing ↗machine: t178 · r9 · c12 · span 1229847–1229853 |
| 14 | Section 03, Amy Landucci PSU | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Grants of plan-based awards” · grants of plan-based awards table. Filing ↗machine: t178 · r35 · c12 · span 1294824–1294830 |
| 15 | Section 03, Christopher Barry PSU | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Grants of plan-based awards” · grants of plan-based awards table. Filing ↗machine: t178 · r42 · c12 · span 1312530–1312536 |
| 16 | Section 03, Wayde McMillan PSU | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Grants of plan-based awards” · grants of plan-based awards table. Filing ↗machine: t178 · r16 · c12 · span 1247559–1247565 |
| 17 | Section 03, Marcela Kirberger PSU | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Grants of plan-based awards” · grants of plan-based awards table. Filing ↗machine: t178 · r28 · c11 · span 1277436–1277442 |
| 18 | Section 07, pay ratio | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “CEO Pay Ratio”. As printed: 245 : 1. Filing ↗ |
| 19 | Section 08, Carrie S. Cox | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Director Compensation”. As printed: 495,046. Filing ↗machine: t104 · r7 · c6 · span 768315–768322 |
| 20 | Section 08, Glenn A. Eisenberg | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Director Compensation”. As printed: 370,006. Filing ↗machine: t104 · r16 · c6 · span 773992–773999 |
| 21 | Section 08, Karen J. May | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Director Compensation”. As printed: 365,006. Filing ↗machine: t104 · r22 · c6 · span 777770–777777 |
| 22 | Section 08, Susan D. DeVore | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Director Compensation”. As printed: 360,006. Filing ↗machine: t104 · r10 · c6 · span 770217–770224 |
| 23 | Section 08, John H. Weiland | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Director Compensation”. As printed: 360,006. Filing ↗machine: t104 · r28 · c6 · span 781552–781559 |
| 24 | Section 08, Dr. Bernard A. Harris, Jr | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Director Compensation”. As printed: 345,006. Filing ↗machine: t104 · r19 · c6 · span 775875–775882 |
| 25 | Section 08, Elizabeth A. Mily | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Director Compensation”. As printed: 345,006. Filing ↗machine: t104 · r25 · c6 · span 779644–779651 |
| 26 | Section 08, Shirley A. Edwards | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Director Compensation”. As printed: 345,006. Filing ↗machine: t104 · r13 · c6 · span 772092–772099 |
| 27 | Section 08, Darryl L. Wilson | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Director Compensation”. As printed: 345,006. Filing ↗machine: t104 · r34 · c6 · span 785143–785150 |
| 28 | Section 08, Carlos Albán | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Director Compensation”. As printed: 345,006. Filing ↗machine: t104 · r4 · c6 · span 766277–766284 |
| 29 | Section 08, Amy A. Wendell | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Director Compensation”. As printed: 345,006. Filing ↗machine: t104 · r31 · c6 · span 783420–783427 |
| 30 | Section 08, Bryan C. Hanson | DEF 14A | 2026-03-27 | 0001964738-26-000017 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 31 | Section 02, John H. Weiland 2026-03-27 | Form 4 | 2026-03-30 | 0001204663-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, Carlos Alban 2026-03-27 | Form 4 | 2026-03-30 | 0001474632-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Amy A. Wendell 2026-03-27 | Form 4 | 2026-03-30 | 0001400568-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Darryl L. Wilson 2026-03-27 | Form 4 | 2026-03-30 | 0001755508-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, Mary T. Wilcox 2026-03-27 | Form 4 | 2026-03-30 | 0002016061-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, Mary T. Wilcox 2026-03-27 | Form 4 | 2026-03-30 | 0002016061-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Carrie S. Cox 2026-03-27 | Form 4 | 2026-03-30 | 0001110753-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Carrie S. Cox 2026-03-27 | Form 4 | 2026-03-30 | 0001110753-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Susan D. DeVore 2026-03-27 | Form 4 | 2026-03-30 | 0001587697-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Shirley A. Edwards 2026-03-27 | Form 4 | 2026-03-30 | 0001958161-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Glenn A. Eisenberg 2026-03-27 | Form 4 | 2026-03-30 | 0001222831-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Glenn A. Eisenberg 2026-03-27 | Form 4 | 2026-03-30 | 0001222831-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Dr. Bernard A. Harris, Jr 2026-03-27 | Form 4 | 2026-03-30 | 0001337906-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Elizabeth A. Mily 2026-03-27 | Form 4 | 2026-03-30 | 0001808438-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Darryl L. Wilson 2026-03-27 | Form 4 | 2026-03-30 | 0001755508-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Carlos Alban 2026-03-27 | Form 4 | 2026-03-30 | 0001474632-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Elizabeth A. Mily 2026-03-27 | Form 4 | 2026-03-30 | 0001808438-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Karen J. May 2026-03-27 | Form 4 | 2026-03-30 | 0001161660-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Amy A. Wendell 2026-03-27 | Form 4 | 2026-03-30 | 0001400568-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Susan D. DeVore 2026-03-27 | Form 4 | 2026-03-30 | 0001587697-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Karen J. May 2026-03-27 | Form 4 | 2026-03-30 | 0001161660-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Dr. Bernard A. Harris, Jr 2026-03-27 | Form 4 | 2026-03-30 | 0001337906-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, Mary T. Wilcox 2026-03-27 | Form 4 | 2026-03-30 | 0002016061-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, John H. Weiland 2026-03-27 | Form 4 | 2026-03-30 | 0001204663-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, Shirley A. Edwards 2026-03-27 | Form 4 | 2026-03-30 | 0001958161-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Carlos Alban 2026-04-30 | Form 4 | 2026-05-01 | 0001474632-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, John H. Weiland 2026-04-30 | Form 4 | 2026-05-01 | 0001204663-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, Amy A. Wendell 2026-04-30 | Form 4 | 2026-05-01 | 0001400568-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, John H. Weiland 2026-04-30 | Form 4 | 2026-05-01 | 0001204663-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, Elizabeth A. Mily 2026-04-30 | Form 4 | 2026-05-01 | 0001808438-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, Darryl L. Wilson 2026-04-30 | Form 4 | 2026-05-01 | 0001755508-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, Darryl L. Wilson 2026-04-30 | Form 4 | 2026-05-01 | 0001755508-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 02, Karen J. May 2026-04-30 | Form 4 | 2026-05-01 | 0001161660-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 64 | Section 02, Dr. Bernard A. Harris, Jr 2026-04-30 | Form 4 | 2026-05-01 | 0001337906-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 65 | Section 02, Glenn A. Eisenberg 2026-04-30 | Form 4 | 2026-05-01 | 0001222831-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 66 | Section 02, Shirley A. Edwards 2026-04-30 | Form 4 | 2026-05-01 | 0001958161-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 67 | Section 02, Susan D. DeVore 2026-04-30 | Form 4 | 2026-05-01 | 0001587697-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 68 | Section 02, Susan D. DeVore 2026-04-30 | Form 4 | 2026-05-01 | 0001587697-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 69 | Section 02, Carrie S. Cox 2026-04-30 | Form 4 | 2026-05-01 | 0001110753-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 70 | Section 02, Shirley A. Edwards 2026-04-30 | Form 4 | 2026-05-01 | 0001958161-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 71 | Section 02, Carrie S. Cox 2026-04-30 | Form 4 | 2026-05-01 | 0001110753-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 72 | Section 02, Carlos Alban 2026-04-30 | Form 4 | 2026-05-01 | 0001474632-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 73 | Section 02, Elizabeth A. Mily 2026-04-30 | Form 4 | 2026-05-01 | 0001808438-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 74 | Section 02, Glenn A. Eisenberg 2026-04-30 | Form 4 | 2026-05-01 | 0001222831-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 75 | Section 02, Amy A. Wendell 2026-04-30 | Form 4 | 2026-05-01 | 0001400568-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 76 | Section 02, Dr. Bernard A. Harris, Jr 2026-04-30 | Form 4 | 2026-05-01 | 0001337906-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 77 | Section 02, Karen J. May 2026-04-30 | Form 4 | 2026-05-01 | 0001161660-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 78 | Section 02, Marcela Kirberger 2026-05-13 | Form 4 | 2026-05-15 | 0001868881-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 79 | Section 02, Mary T. Wilcox 2026-05-13 | Form 4 | 2026-05-15 | 0002016061-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 80 | Section 02, Tammy L. Gomez 2026-05-13 | Form 4 | 2026-05-15 | 0001937481-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 81 | Section 02, Tammy L. Gomez 2026-05-13 | Form 4 | 2026-05-15 | 0001937481-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 82 | Section 02, Marcela Kirberger 2026-05-13 | Form 4 | 2026-05-15 | 0001868881-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 83 | Section 02, Mary T. Wilcox 2026-05-13 | Form 4 | 2026-05-15 | 0002016061-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 84 | Section 02, Mary T. Wilcox 2026-05-13 | Form 4 | 2026-05-15 | 0002016061-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 85 | Section 02, Marcela Kirberger 2026-05-13 | Form 4 | 2026-05-15 | 0001868881-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 86 | Section 02, Amy Landucci 2026-05-13 | Form 4 | 2026-05-15 | 0002015813-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 87 | Section 02, Bryan C. Hanson 2026-05-13 | Form 4 | 2026-05-15 | 0001524349-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 88 | Section 02, Paul S. Harrington 2026-05-13 | Form 4 | 2026-05-15 | 0002015932-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 89 | Section 02, Bryan C. Hanson 2026-05-13 | Form 4 | 2026-05-15 | 0001524349-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 90 | Section 02, Wayde McMillan 2026-05-13 | Form 4 | 2026-05-15 | 0001768648-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 91 | Section 02, Amy Landucci 2026-05-13 | Form 4 | 2026-05-15 | 0002015813-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 92 | Section 02, Wayde McMillan 2026-05-13 | Form 4 | 2026-05-15 | 0001768648-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 93 | Section 02, Wayde McMillan 2026-05-13 | Form 4 | 2026-05-15 | 0001768648-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 94 | Section 02, Paul S. Harrington 2026-05-13 | Form 4 | 2026-05-15 | 0002015932-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 95 | Section 02, Paul S. Harrington 2026-05-13 | Form 4 | 2026-05-15 | 0002015932-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 96 | Section 02, Tammy L. Gomez 2026-05-13 | Form 4 | 2026-05-15 | 0001937481-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 97 | Section 02, Amy Landucci 2026-05-13 | Form 4 | 2026-05-15 | 0002015813-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 98 | Section 02, Bryan C. Hanson 2026-05-13 | Form 4 | 2026-05-15 | 0001524349-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 99 | Section 02, Glenn A. Eisenberg 2026-05-15 | Form 4 | 2026-05-18 | 0001222831-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 100 | Section 02, Darryl L. Wilson 2026-05-15 | Form 4 | 2026-05-18 | 0001755508-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 101 | Section 02, Carrie S. Cox 2026-05-15 | Form 4 | 2026-05-18 | 0001110753-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 102 | Section 02, Karen J. May 2026-05-15 | Form 4 | 2026-05-18 | 0001161660-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 103 | Section 02, Elizabeth A. Mily 2026-05-15 | Form 4 | 2026-05-18 | 0001808438-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 104 | Section 02, Susan D. DeVore 2026-05-15 | Form 4 | 2026-05-18 | 0001587697-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 105 | Section 02, Shirley A. Edwards 2026-05-15 | Form 4 | 2026-05-18 | 0001958161-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 106 | Section 02, Dr. Bernard A. Harris, Jr 2026-05-15 | Form 4 | 2026-05-18 | 0001337906-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 107 | Section 02, Amy A. Wendell 2026-05-15 | Form 4 | 2026-05-18 | 0001400568-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 108 | Section 02, John H. Weiland 2026-05-15 | Form 4 | 2026-05-18 | 0001204663-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 109 | Section 02, Carlos Alban 2026-05-15 | Form 4 | 2026-05-18 | 0001474632-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 110 | Section 06, 2026 vote | Form 8-K | 2026-05-20 | 0001964738-26-000027 | Item 5.07 · say-on-pay result. As reported: 74.19% (votes for as printed: 105,240,522). Filing ↗ |
| 111 | Section 06, 2025 vote | Form 8-K | 2025-05-02 | 0001964738-25-000043 | Item 5.07 · say-on-pay result. As reported: 85.92% (votes for as printed: 117,421,361). Filing ↗ |
| 112 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 113 | Section 09b board cost (computed) | Computed | — | computed | Cash 1,445,000 + equity 2,575,106 + all other 0 = 4,020,106, summed across the director compensation table rows.machine: formula: Σ = 4,020,106 |
| 114 | Baxter International Inc., Section 10b CEO total | DEF 14A | 2026-03-23 | 0001628280-26-020330 | CEO total compensation as printed in Baxter International Inc.'s own proxy. As printed: 29,805,182. Filing ↗machine: r4 · c30 · span 1451066–1451076 |
| 115 | IQVIA Holdings Inc., Section 10b CEO total | DEF 14A | 2026-02-27 | 0001628280-26-012892 | CEO total compensation as printed in IQVIA Holdings Inc.'s own proxy. As printed: 28,128,245. Filing ↗machine: t232 · r4 · c10 · span 1613956–1613966 |
| 116 | Danaher Corporation, Section 10b CEO total | DEF 14A | 2026-03-25 | 0000313616-26-000101 | CEO total compensation as printed in Danaher Corporation's own proxy. As printed: 23,795,280. Filing ↗machine: t122 · r2 · c21 · span 1070180–1070190 |
| 117 | Boston Scientific Corporation, Section 10b CEO total | DEF 14A | 2026-03-18 | 0000885725-26-000025 | CEO total compensation as printed in Boston Scientific Corporation's own proxy. As printed: 23,532,050. Filing ↗machine: r2 · c27 · span 1249807–1249817 |
| 118 | Medtronic plc, Section 10b CEO total | DEF 14A | 2026-08-17 | 0001613103-26-000010 | CEO total compensation as printed in Medtronic plc's own proxy. As printed: 22,940,252. Filing ↗machine: span 988220–988230 |
| 119 | Stryker Corporation, Section 10b CEO total | DEF 14A | 2026-03-23 | 0000310764-26-000013 | CEO total compensation as printed in Stryker Corporation's own proxy. As printed: 21,401,495. Filing ↗machine: t101 · r2 · c7 · span 1584979–1584989 |
| 120 | Intuitive Surgical, Inc., Section 10b CEO total | DEF 14A | 2026-03-13 | 0001035267-26-000023 | CEO total compensation as printed in Intuitive Surgical, Inc.'s own proxy. As printed: 20,997,480. Filing ↗machine: r2 · c48 · span 762289–762299 |
| 121 | Solventum Corp (subject), Section 10b CEO total | DEF 14A | 2026-03-27 | 0001964738-26-000017 | CEO total compensation as printed in Solventum Corp's own proxy. As printed: 20,139,981. Filing ↗machine: r4 · c30 · span 1137286–1137296 |
| 122 | Align Technology, Inc., Section 10b CEO total | DEF 14A | 2026-04-07 | 0001097149-26-000023 | CEO total compensation as printed in Align Technology, Inc.'s own proxy. As printed: 19,193,988. Filing ↗machine: r2 · c42 · span 933168–933178 |
| 123 | GE HealthCare Technologies Inc., Section 10b CEO total | DEF 14A | 2026-03-19 | 0001932393-26-000021 | CEO total compensation as printed in GE HealthCare Technologies Inc.'s own proxy. As printed: 18,562,794. Filing ↗machine: t113 · r3 · c20 · span 924977–924987 |
| 124 | Edwards Lifesciences Corporation, Section 10b CEO total | DEF 14A | 2026-03-26 | 0001099800-26-000015 | CEO total compensation as printed in Edwards Lifesciences Corporation's own proxy. As printed: 17,454,255. Filing ↗machine: r2 · c27 · span 965441–965451 |
| 125 | Becton, Dickinson and Company, Section 10b CEO total | DEF 14A | 2025-12-18 | 0001628280-25-057846 | CEO total compensation as printed in Becton, Dickinson and Company's own proxy. As printed: 17,129,140. Filing ↗machine: r2 · c27 · span 1173285–1173295 |
| 126 | Zimmer Biomet Holdings, Inc., Section 10b CEO total | DEF 14A | 2026-04-01 | 0001193125-26-135661 | CEO total compensation as printed in Zimmer Biomet Holdings, Inc.'s own proxy. As printed: 16,106,550. Filing ↗machine: t111 · r3 · c16 · span 1895785–1895795 |
| 127 | The Cooper Companies, Inc., Section 10b CEO total | DEF 14A | 2026-02-24 | 0001628280-26-011110 | CEO total compensation as printed in The Cooper Companies, Inc.'s own proxy. As printed: 16,051,141. Filing ↗machine: t120 · r3 · c14 · span 744904–744914 |
| 128 | Hologic, Inc., Section 10b CEO total | DEF 14A | 2025-01-16 | 0001140361-25-001287 | CEO total compensation as printed in Hologic, Inc.'s own proxy. As printed: 15,819,261. Filing ↗machine: r2 · c25 · span 1549664–1549674 |
| 129 | ResMed Inc., Section 10b CEO total | DEF 14A | 2025-10-02 | 0000943819-25-000079 | CEO total compensation as printed in ResMed Inc.'s own proxy. As printed: 14,674,543. Filing ↗machine: span 1328668–1328678 |
| 130 | Fortive Corporation, Section 10b CEO total | DEF 14A | 2026-04-29 | 0001193125-26-189078 | CEO total compensation as printed in Fortive Corporation's own proxy. As printed: 14,405,012. Filing ↗machine: r5 · c17 · span 4058481–4058492 |
| 131 | Agilent Technologies, Inc., Section 10b CEO total | DEF 14A | 2026-02-06 | 0001193125-26-040286 | CEO total compensation as printed in Agilent Technologies, Inc.'s own proxy. As printed: 12,827,236. Filing ↗machine: r3 · c29 · span 1450982–1450992 |
| 132 | STERIS plc, Section 10b CEO total | DEF 14A | 2026-06-11 | 0001193125-26-267599 | CEO total compensation as printed in STERIS plc's own proxy. As printed: 11,508,522. Filing ↗machine: t172 · r6 · c34 · span 820590–820600 |
| 133 | DENTSPLY SIRONA Inc., Section 10b CEO total | DEF 14A | 2026-04-23 | 0000818479-26-000125 | CEO total compensation as printed in DENTSPLY SIRONA Inc.'s own proxy. As printed: 8,760,139. Filing ↗machine: r5 · c27 · span 1201378–1201387 |
| 134 | Avantor, Inc., Section 10b CEO total | DEF 14A | 2026-03-27 | 0001628280-26-021572 | CEO total compensation as printed in Avantor, Inc.'s own proxy. As printed: 5,895,624. Filing ↗machine: r3 · c9 · span 2130032–2130041 |
| 135 | Section 10a, GE HealthCare Technologies Inc. reciprocity | DEF 14A | — | 0001932393-26-000021 | GE HealthCare Technologies Inc.'s most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 136 | Section 10a, Boston Scientific Corporation reciprocity | DEF 14A | — | 0000885725-26-000025 | Boston Scientific Corporation's most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 137 | Section 10a, Stryker Corporation reciprocity | DEF 14A | — | 0000310764-26-000013 | Stryker Corporation's most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 138 | Section 10a, Edwards Lifesciences Corporation reciprocity | DEF 14A | — | 0001099800-26-000015 | Edwards Lifesciences Corporation's most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 139 | Section 10a, IQVIA Holdings Inc. reciprocity | DEF 14A | — | 0001628280-26-012892 | IQVIA Holdings Inc.'s most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 140 | Section 10a, Baxter International Inc. reciprocity | DEF 14A | — | 0001628280-26-020330 | Baxter International Inc.'s most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 141 | Section 10a, Danaher Corporation reciprocity | DEF 14A | — | 0000313616-26-000101 | Danaher Corporation's most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 142 | Section 10a, The Cooper Companies, Inc. reciprocity | DEF 14A | — | 0001628280-26-011110 | The Cooper Companies, Inc.'s most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 143 | Section 10a, Zimmer Biomet Holdings, Inc. reciprocity | DEF 14A | — | 0001193125-26-135661 | Zimmer Biomet Holdings, Inc.'s most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 144 | Section 10a, Align Technology, Inc. reciprocity | DEF 14A | — | 0001097149-26-000023 | Align Technology, Inc.'s most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 145 | Section 10a, Avantor, Inc. reciprocity | DEF 14A | — | 0001628280-26-021572 | Avantor, Inc.'s most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 146 | Section 10a, Hologic, Inc. reciprocity | DEF 14A | — | 0001140361-25-001287 | Hologic, Inc.'s most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 147 | Section 10a, Intuitive Surgical, Inc. reciprocity | DEF 14A | — | 0001035267-26-000023 | Intuitive Surgical, Inc.'s most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 148 | Section 10a, Agilent Technologies, Inc. reciprocity | DEF 14A | — | 0001193125-26-040286 | Agilent Technologies, Inc. names Solventum Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 149 | Section 10a, ResMed Inc. reciprocity | DEF 14A | — | 0000943819-25-000079 | ResMed Inc.'s most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 150 | Section 10a, STERIS plc reciprocity | DEF 14A | — | 0001193125-26-267599 | STERIS plc's most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 151 | Section 10a, Becton, Dickinson and Company reciprocity | DEF 14A | — | 0001628280-25-057846 | Becton, Dickinson and Company's most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 152 | Section 10a, DENTSPLY SIRONA Inc. reciprocity | DEF 14A | — | 0000818479-26-000125 | DENTSPLY SIRONA Inc.'s most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |
| 153 | Section 10a, Fortive Corporation reciprocity | DEF 14A | — | 0001193125-26-189078 | Fortive Corporation's most recent proxy was read; its disclosed peer group does not include Solventum Corp. Filing ↗ |